| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963726 | Vaccine | 2015 | 6 Pages |
Abstract
A two dose schedule with Euvichol induces a strong vibriocidal response comparable to those elicited by the currently WHO prequalified OCV, Shanchol. Euvichol will be an oral cholera vaccine suitable for use in lower income countries, where cholera still has a significant economic and public health impact.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Yeong Ok Baik, Seuk Keun Choi, Remigio M. Olveda, Roberto A. Espos, Antonio D. Ligsay, May B. Montellano, Jong Sun Yeam, Jae Seung Yang, Ju Yeon Park, Deok Ryun Kim, Sachin N. Desai, Ajit Pal Singh, Ick Young Kim, Chan Wha Kim, Sue-nie Park,